Treace to Report Third Quarter 2026 Financial Results on November 6, 2026
PONTE VEDRA, Fla., Oct. 23, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that it will release financial results for the third quarter 2026 before the start of trading on Friday, November 6, 2026. Company management will host a conference call to discuss financial results beginning at 8:00 am ET.
Covered in this story
Call it yourself
No calls on $TMCI yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Treace Medical Concepts Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.